Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS
申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US10407374B2
公开(公告)日:2019-09-10
The invention provides compositions and methods for ameliorating, treating, reversing or preventing pathology or inflammation in the central nervous system (CNS), or the brain, caused or mediated by NFkB, IL-6, IL-6-R, NADPH oxidase (Nox), and/or superoxide and/or hydrogen peroxide production by a NADPH oxidase, including for example ameliorating, treating, reversing or preventing schizophrenia, psychosis, delirium, e.g., post-operative delirium, drug-induced psychosis, psychotic features associated with frailty syndrome (FS), aging, depression, dementias; traumatic war neurosis, post traumatic stress disorder (PTSD) or post-traumatic stress syndrome (PTSS), Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's Disease), and/or Multiple Sclerosis (MS). The invention also provides methods for purifying a C60 fullerene, C3 (tris malonic acid C60) or malonic acid derivatives.
本发明提供了用于改善、治疗、逆转或预防由 NFkB、IL-6、IL-6-R、
NADPH 氧化酶(Nox)和/或
NADPH 氧化酶产生的超氧化物和/或
过氧化氢引起或介导的中枢神经系统(CNS)或大脑中的病理或炎症的组合物和方法,包括例如改善、治疗、逆转或预防精神分裂症、精神病、谵妄,例如术后谵妄、药物诱发的精神病、与虚弱综合征(FS)相关的精神病特征、衰老、抑郁、痴呆症;创伤性战争神经症、创伤后应激障碍、创伤性战争神经症、创伤后应激障碍(
PTSD)或创伤后应激综合征(PTSS)、肌萎缩侧索硬化症(ALS,或卢伽雷氏症)和/或多发性硬化症(MS)。本发明还提供了纯化 C60
富勒烯、C3(三
丙二酸 C60)或
丙二酸衍
生物的方法。